BrightSpec Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 9
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $2.29M
Latest Deal Amount
  • Investors
  • 7

BrightSpec General Information

Description

Developer of advanced spectrometer intended to offer a fast and precise analysis of trace level chemical compounds. The company's spectrometer utilizes Molecular Rotational Resonance (MRR) spectroscopy to analyze mutagenic impurities, determine residual solvent content of polar solvents and trace small polar impurities in industrial gases and other samples, enabling chemical manufacturers to analyze complex mixtures in a better way without the need of chromatography.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Commercial Products
Other Industries
Industrial Chemicals
Primary Office
  • 770 Harris Street
  • Suite 104b
  • Charlottesville, VA 22903
  • United States
+1 (434) 000-0000

BrightSpec Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BrightSpec Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series B) 01-Aug-2020 $2.29M 00.000 00.000 Completed Generating Revenue
5. Debt - PPP 07-Apr-2020 00.000 Completed Generating Revenue
4. Grant 20-Aug-2018 00000 00.000 Completed Generating Revenue
3. Early Stage VC (Series A2) 01-Aug-2017 00.000 00.000 00.000 Completed Product Development
2. Grant 01-Jan-2016 $2M $2M Completed Product Development
1. Early Stage VC (Series A) 18-Mar-2013 $2M $2M 000 Completed Startup
To view BrightSpec’s complete valuation and funding history, request access »

BrightSpec Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A-2 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A-1 2,000,000 $0.000100 8% $1 $1 1x $1 12.05%
To view BrightSpec’s complete cap table history, request access »

BrightSpec Executive Team (9)

Name Title Board Seat Contact Info
Walter Colsman Chief Executive Officer & Board Member
Dave McDaniel Co-Founder, Chief Operating Officer and Senior Software Architect
Justin Neill Ph.D Co-Founder & Chief Technology Officer
Matt Muckle Co-Founder, Software Developer and Applications Scientist
Brooks Pate Ph.D Co-Founder
You’re viewing 5 of 9 executive team members. Get the full list »

BrightSpec Board Members (6)

Name Representing Role Since
David Cash Medvest Capital Board Member 000 0000
Jaffray Woodriff BrightSpec Board Member 000 0000
Robert Creeden Self Board Member 000 0000
Walter Colsman BrightSpec Chief Executive Officer & Board Member 000 0000
You’re viewing 4 of 6 board members. Get the full list »

BrightSpec Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BrightSpec Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CAV Angels Angel Group Minority 000 0000 000000 0
Medvest Capital Venture Capital Minority 000 0000 000000 0
UVA LVG Seed Fund Venture Capital Minority 000 0000 000000 0
Virginia Biosciences Health Research Corporation Other 000 0000 000000 0
Keysight Technologies Corporation Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »